HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshitomo Notsu Selected Research

N,N-dimethylarginine (asymmetric dimethylarginine)

3/2015Plasma arginine/ADMA ratio as a sensitive risk marker for atherosclerosis: Shimane CoHRE study.
4/2011Asymmetric dimethylarginine as a risk factor for cardiovascular disease in Japanese patients with type 2 diabetes mellitus.
10/2010Relationships between dimethylarginine and the presence of vertebral fractures in type 2 diabetes mellitus.
3/2009Evaluation of asymmetric dimethylarginine and homocysteine in microangiopathy-related cerebral damage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshitomo Notsu Research Topics

Disease

4Atherosclerosis
02/2023 - 02/2009
3Cardiovascular Diseases (Cardiovascular Disease)
02/2023 - 04/2011
2Carcinoma (Carcinomatosis)
12/2022 - 07/2020
2Neoplasms (Cancer)
12/2022 - 07/2020
2Hypertension (High Blood Pressure)
05/2022 - 08/2007
2Type 2 Diabetes Mellitus (MODY)
04/2011 - 10/2010
1Fibrosis (Cirrhosis)
11/2023
1Liver Cirrhosis (Hepatic Cirrhosis)
11/2023
1Colonic Neoplasms (Colon Cancer)
12/2022
1isovaleric Acidemia
05/2022
1Stroke (Strokes)
05/2022
1Lysosomal Storage Diseases (Lysosomal Storage Disease)
03/2020
1Mucopolysaccharidosis III (Sanfilippo Syndrome)
03/2020
1Mucopolysaccharidoses
03/2020
1Mucopolysaccharidosis IV (Morquio Syndrome)
03/2020
1Hypotension (Low Blood Pressure)
04/2011
1Osteoporotic Fractures
10/2010
1Malnutrition (Nutritional Deficiencies)
07/2009
1Inflammation (Inflammations)
07/2009
1Arteriosclerosis
03/2009
1Alzheimer Disease (Alzheimer's Disease)
05/2008
1Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
05/2008
1Central Nervous System Diseases (CNS Diseases)
05/2008
1Neoplasm Metastasis (Metastasis)
05/2008
1Abdominal Obesity
08/2007
1Metabolic Syndrome (Dysmetabolic Syndrome X)
08/2007
1Insulin Resistance
08/2007

Drug/Important Bio-Agent (IBA)

4N,N-dimethylarginine (asymmetric dimethylarginine)IBA
03/2015 - 03/2009
3Arginine (L-Arginine)FDA Link
12/2022 - 03/2015
2C-Reactive ProteinIBA
11/2023 - 07/2009
2Peptides (Polypeptides)IBA
05/2022 - 07/2020
2Amino AcidsFDA Link
05/2022 - 07/2020
2Nitric Oxide Synthase (NO Synthase)IBA
03/2015 - 10/2010
2oxidized low density lipoproteinIBA
04/2011 - 02/2009
2Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2010 - 03/2009
1lysophosphatidic acidIBA
11/2023
1Collagen Type IV (Type IV Collagen)IBA
11/2023
1trimethyloxamine (trimethylamine N-oxide)IBA
02/2023
1trimethyllysineIBA
02/2023
1Carnitine (L-Carnitine)FDA LinkGeneric
02/2023
1Choline (Choline Chloride)IBA
02/2023
1Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2022
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2022
1Fluorouracil (Carac)FDA LinkGeneric
12/2022
1ArginaseIBA
12/2022
13-methylbutyrylcarnitineIBA
05/2022
1pivaloylcarnitineIBA
05/2022
1Indicators and Reagents (Reagents)IBA
05/2022
1SpermidineIBA
05/2022
1SaltsIBA
05/2022
1Tryptophan (L-Tryptophan)FDA Link
07/2020
1EnzymesIBA
03/2020
1GlycosaminoglycansIBA
03/2020
1Lipoproteins (Lipoprotein)IBA
04/2011
1symmetric dimethylarginineIBA
04/2011
1HDL CholesterolIBA
04/2011
1HDL LipoproteinsIBA
04/2011
1dimethylarginineIBA
10/2010
1Prealbumin (Transthyretin)IBA
07/2009
1Proteins (Proteins, Gene)FDA Link
07/2009
1HomocysteineIBA
03/2009
1LDL CholesterolIBA
02/2009
1CathepsinsIBA
05/2008
1Amyloid (Amyloid Fibrils)IBA
05/2008
1Cystatin CIBA
05/2008
1Glucose (Dextrose)FDA LinkGeneric
08/2007

Therapy/Procedure

1Therapeutics
12/2022